Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ZIOPHARM ONCOLOGY INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 11.38 M 35.03 M 28.41 M 8.88 M 1.03 M
    Net Receivables 0.00 0.00 0.00 0.00 0.00
    Total Inventories
    Progress Payments & Others
    Prepaid Expenses
    Other Current Assets 327,000.00 498,864.00 462,789.00 211,837.00 117,571.00
    Current Assets Total 11.71 M 35.53 M 28.87 M 9.09 M 1.14 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 60,000.00 0.00 9,367.00 5,700.00 60,046.00
    Property, Plant & Equipment Net 489,000.00 746,421.00 451,247.00 269,702.00 240,733.00
    Property, Plant & Equipment Gross 999,000.00 1.04 M 758,746.00 404,888.00 274,686.00
    Accumulated Depreciation 510,000.00 291,467.00 307,499.00 135,186.00 33,953.00
    Other Assets 318,000.00 452,378.00 178,080.00 124,343.00 0.00
    Deferred Charges 0.00 0.00 0.00
    Tangible Other Assets 318,000.00 178,080.00 124,343.00 0.00
    Intangible Other Assets
    Total Assets 12.57 M 36.73 M 29.51 M 9.49 M 1.45 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 51,000.00 275,000.00 637,836.00 448,433.00 506,391.00
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 3.09 M 3.12 M 1.52 M 970,386.00 372,985.00
    Current Liabilities Total 5.78 M 6.31 M 2.94 M 2.25 M 1.59 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges 0.00 0.00 0.00 0.00 0.00
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 58,000.00 50,988.00 41,078.00 35,557.00 0.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 0.00 0.00 0.00 0.00 0.00
    Total Liabilities 5.83 M 6.36 M 2.98 M 2.29 M 1.59 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 6.74 M 30.37 M 26.53 M 7.20 M -144,317.00
    Common Stock 22,000.00 21,299.00 15,273.00 7,248.00 2,761.00
    Capital Surplus 71.27 M 69.67 M 44.67 M 22.56 M 5.70 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 20.50 M 20.50 M 15.07 M 0.00 0.00
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -85.06 M -59.83 M -33.22 M -15.36 M -5.85 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 0.00 0.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 12.57 M 36.73 M 29.51 M 9.49 M 1.45 M
    Common Shares Outstanding 21.86 M 21.30 M 15.27 M 181,203.00 2.76 M